An in vitro neurogenetics platform for precision disease modeling in the mouse

Area of Science:

• Genetics
• Genomics
• Developmental Biology

Background:

• Single inbred mouse strains may not accurately model human diseases due to limited genetic diversity.
• Incorporating broad genetic diversity significantly enhances the power and scope of disease modeling.

Purpose of the Study:

• To develop a cross-species precision disease modeling platform that bridges cell-based and whole-organism analysis.
• To exploit mouse genetic diversity for more accurate disease modeling.
• To functionally analyze candidate disease variants identified in human genetic studies.

Main Methods:

• Developed a universal protocol for robust neural differentiation of diverse human and mouse pluripotent stem cell lines.
• Conducted a proof-of-concept study using the neurodevelopmental gene DYRK1A.
• Utilized transcriptomic analysis to compare responsive and unresponsive genetic strains.

Main Results:

• In vitro results reliably predicted in vivo effects of genetic background on Dyrk1a loss-of-function phenotypes.
• Identified molecular pathways conferring sensitivity or resilience to DYRK1A loss.
• Highlighted differential messenger RNA isoform usage as a key determinant of response.

Conclusions:

• The developed cross-species strategy is a powerful tool for functional analysis of candidate disease variants.
• This platform enhances disease modeling by incorporating genetic diversity.
• Accurate prediction of gene function effects across species and model systems is achievable.